• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Denileukin Diftitox

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO
Symbol
Referenced
Subgroup
Labeling Sections with
Pharmacogenomic
Information
Denileukin DiftitoxOncologyIL2RACD25 antigen positiveIndications and Usage
Warnings and Precautions
Clinical Studies

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling